One-a-day Dry Eye
Natural health product licensed in Canada
- Licence holder
- Nutricorp International
- NPN or DIN-HM
- 80062595
- Status
- Active licence
- Licence date
- 9 July 2015
- Revision date
- Not provided
- Form
- Capsule, remplie de liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 240 milligramme Docosahexaenoic acid | 1,050 milligramme | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 360 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Glycérine, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of EPA and DHA for the maintenance of good health. Helps to maintain and support cardiovascular health. Helps support cognitive health and/or brain function. A source of omega-3 fatty acids for the maintenance of good health. Helps relieve symptoms of Dry Eye Syndrome. Helps improve symptoms of Dry Eye Syndrome. Helps provide relief/improve symptoms of dry eye syndrome including support for proper tear function (decreased rate of tear evaporation and increase in tear secretion). Helps support proper tear function in persons with Dry Eye Syndrome. Helps decrease the rate of tear evaporation in persons with Dry Eye Syndrome. Helps increase tear secretion in persons with Dry Eye Syndrome.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80062595
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.